Stay updated on Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial
Sign up to get notified when there's something new on the Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial page.

Latest updates to the Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial page
- Check5 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedNew revision entry added to the history, updating the version from v3.6.6 to v3.7.0. This reflects an updated page version without changing the underlying study data.SummaryDifference0.1%

- Check47 days agoChange DetectedA new Revision: v3.6.6 entry was added to the study history, and the previous Revision: v3.6.5 was removed. This represents a small maintenance update to the page's revision log.SummaryDifference0.1%

- Check69 days agoChange DetectedNew revision v3.6.5 has been added to the study record history. The previous revision v3.6.4 has been removed from the history log.SummaryDifference0.1%

- Check83 days agoChange DetectedA new revision label was added to the page history, updating the version from v3.6.3 to v3.6.4 in the Study Record Versions. This reflects a minor internal update to the ClinicalTrials.gov interface and does not modify the study details.SummaryDifference0.1%

- Check104 days agoChange DetectedThe record history now shows the latest revision tag as v3.6.3, replacing the previous v3.6.2.SummaryDifference0.1%

Stay in the know with updates to Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lixivaptan Safety Assessment in ADPKD Completion: Clinical Trial page.